Cargando…

Ozanimod for multiple sclerosis

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: NPS MedicineWise 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8075748/
https://www.ncbi.nlm.nih.gov/pubmed/33911338
http://dx.doi.org/10.18773/austprescr.2021.013
_version_ 1783684580660740096
collection PubMed
description
format Online
Article
Text
id pubmed-8075748
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher NPS MedicineWise
record_format MEDLINE/PubMed
spelling pubmed-80757482021-04-27 Ozanimod for multiple sclerosis Aust Prescr New Drugs NPS MedicineWise 2021-03-10 2021-04 /pmc/articles/PMC8075748/ /pubmed/33911338 http://dx.doi.org/10.18773/austprescr.2021.013 Text en (c) NPS MedicineWise https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND) 4.0 License.
spellingShingle New Drugs
Ozanimod for multiple sclerosis
title Ozanimod for multiple sclerosis
title_full Ozanimod for multiple sclerosis
title_fullStr Ozanimod for multiple sclerosis
title_full_unstemmed Ozanimod for multiple sclerosis
title_short Ozanimod for multiple sclerosis
title_sort ozanimod for multiple sclerosis
topic New Drugs
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8075748/
https://www.ncbi.nlm.nih.gov/pubmed/33911338
http://dx.doi.org/10.18773/austprescr.2021.013